Photo from LSEG

Equity capital markets off to slow start, down 54.2% YoY

Of the total proceeds raised in 1Q24, US$458.95m were via follow-on offerings.

Singapore’s equity capital markets (ECM) had a sluggish start to the year, raising 54.2% YoY lower proceeds, totalling US$490.4m.

Of the total proceeds raised in 1Q24, US$458.95m (-40.1% YoY) were via follow-on offerings.

The remaining US$31.45m were from two IPOs issued by the Singapore Institute of Advanced Medicine (US$19.4m) in a Catalist listing and Ryde Group in a New York listing (US$12m).

Singapore Institute of Advanced Medicine’s listing was the biggest Singaporean-issued IPO so far in 2024, according to the London Stock Exchange Group (LSEG).

By sector, the largest contributor to Singapore’s ECM was the real estate sector, raising US$238.2m in proceeds and accounting for 48.6% of the market share. The real estate sector’s proceeds for the period, however, were down 13.0% compared to 1Q23.

Industrials and High Technology were close behind with 40.6% and 6.5% market share, respectively.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.